-
- 2021.12.23Release
- Notice of Listing on TSE Mothers
-
- 2021.11.18Release
- Notice of Approval for Listing on TSE Mothers
-
- 2021.11.17Release
- Building the MLOps Environment to Automate the ML Pipeline for a Logistics Company
– The accelerated operation of machine learning models for forecasting Yamato Transport’s workload makes it possible to continuously develop new functions and improve the accuracy of the ML models –
-
- 2021.10.11Release
- ExaWizards Forms a Business Tie-up with CyberAgent
—With exaBase, an artificial intelligence (AI)–enabled platform, the two companies will be able to provide one-stop AI and digital transformation (DX) services development solutions fully committed to a wide range of supports, including those for “user growth.”
-
- 2021.10.05Release
- Welcoming Ms. Naoko Munakata, Former Commissioner of Japan Patent Office, As Outside Director of ExaWizards
-
- 2021.08.30Release
- ExaWizards, Astellas Pharma, Juntendo University and Dr. Arai, Chairman of National Center for Geriatrics and Gerontology Jointly Developed Gait Function Assessment Application* for Medical Professionals
—Launched the verification tests on musculoskeletal care support for elderly people at three hospitals in Japan
-
- 2021.08.26Release
- “Intercom Function” Added to “CareWiz Hanasuto-kiroku”, an AI-based, Nursing Care Recording Application Up to 7.5 million yen may subsidized
—Enabling voice communication and information sharing among staff in addition to nursing care record
-
- 2021.08.25Release
- ExaWizards Released “exaBase”, the Platform that Integrates AI/DX Services for Enterprises
—Support to generate outcomes as directly as possible by combining abundant technological assets accumulated through more than 300 AI/DX cases annually
-
- 2021.08.23Release
- ExaWizards and Sumitomo Life Insurance Formed a Business Tie-up in the “Well-being Tech” Field
Part of Shares Acquired by “SUMISEI INNOVATION FUND”
-
- 2021.08.11Release
- ExaWizards and Kyoto University Jointly Developed AI to Evaluate the Text-based Reports Data on Safety of Pharmaceutical Products
—Helping to increase efficiency in the reports evaluation and contributing to promote safer use of pharmaceutical products
